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erMatthew C. Edmundson, Michael Capeness and Louise HorsfallSchool of Biological Sciences, University of Edinburgh, Edinburgh EH9 3JR, UKThe fields of metallic nanoparticle study and synthetic biology have a great deal to offer one another.
Metallic nanoparticles as a class ofmaterial havemany useful properties. Their small size allows formore
points of contact thanwould be the case with a similar bulk compound,making nanoparticles excellent
candidates for catalysts or for when increased levels of binding are required. Some nanoparticles have
unique optical qualities, making them well suited as sensors, while others display para-magnetism,
useful in medical imaging, especially by magnetic resonance imaging (MRI). Many of these metallic
nanoparticles could be used in creating tools for synthetic biology, and conversely the use of synthetic
biology could itself be utilised to create nanoparticle tools. Examples givenhere include the potential use
of quantum dots (QDs) and gold nanoparticles as sensing mechanisms in synthetic biology, and the use
of synthetic biology to create nanoparticle-sensing devices based on currentmethods of detectingmetals
and metalloids such as arsenate. There are a number of organisms which are able to produce a range of
metallic nanoparticles naturally, such as species of the fungus Phoma which produces anti-microbial
silver nanoparticles. The biological synthesis of nanoparticles may have many advantages over their
more traditional industrial synthesis. If the proteins involved in biological nanoparticle synthesis can be
put into a suitable bacterial chassis then they might be manipulated and the pathways engineered in
order to produce more valuable nanoparticles.Introduction
The study of the creation and application of nanoparticles forms
an up-and-coming branch of materials science. Typically defined
as being a material on the nano-scale (anywhere from 1 to 100 nm
in one of their dimensions [1]), we are employing nanoparticles in
an ever increasing number of applications in medicine and indus-
try [2,3], and as new tools to aid fundamental scientific research
[4]. Nanoparticle properties are very diverse. The properties of the
coremolecule used, whatmodifications and functionalisations are
made, their size and shape, and any secondary or tertiary struc-
tures the nanoparticles are able to form all give rise to the multi-
tude of useful properties nanoparticles exhibit. Their small surfaceCorresponding authors: Edmundson, M.C. (medmunds@staffmail.ed.ac.uk),
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572 1871-6784/ 2014 The Authors. Published by Elsevier B.area to volume ratios make them ideal for use as catalysts [5] and
the crystal structures some nanoparticles form have unique optical
properties [6]. There are many different types of nanoparticles,
from lipid-based vesicles for drug delivery to the carbon nano-
tube, but one of the more diverse and wide-spread types is the
metallic nanoparticle. This review will give a brief outline of metal
nanoparticles, before looking at how the fields of metallic nano-
particle research and synthetic biology could come together with
huge benefits to both.
Metallic nanoparticles
Many metal and metalloid elements are able to form nano-scale
structures. Some of the better known nanoparticles currently
being investigated include those based on silver, which are known
for their anti-microbial and anti-inflammatory properties [7].http://dx.doi.org/10.1016/j.nbt.2014.03.004
V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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TABLE 1
Summary of the metallic nanoparticles produced by various
prokaryotic (A) and eukaryotic (B) organisms
Bacterial strain Metal nanoparticles produced
A
Desulfovibrio sp. Au, Cr, Pd, Pt
Magnetospirillum gryphiswaldense Fe
Shewanella sp. Fe
Cupriavidus metallidurans Cd, Cu, Co, Ge, Ni, Pb, Pd, Y, Zn
Pseudomonas sp. Ag, Co, Fe, Li, Ni, Pd, Pt, Rh, Ru
Organism Metal nanoparticles produced
B
Phoma sp. Ag









erSilver has long been known for its ability to combat infection [8],
being able to inhibit various aspects of respiration; silver
nanoparticles have larger surface areas, increasing the area avail-
able for interactions, making them even more effective anti-mi-
crobial agents [9]. Gold nanoparticles are being utilised in
imaging, with colloidal gold nanoparticles used in the immuno-
gold labelling of samples to be viewed using transmission electron
microscopy (TEM) [10]. The gold nanoparticles are conjugated to a
secondary antibody able to bind to a primary antibody, which in
turn is raised against a specific target. The electron-dense gold
nanoparticles show up as dark spots, allowing the target to be
visualised. Also used in imaging are magnetic nanoparticles as
contrast agents inmagnetic resonance imaging (MRI) scans. There is
a wide range of para-magnetic metal nanoparticles, mostly but not
exclusively based on iron. When an external magnetic field is
applied thesenanoparticles becomemagnetic themselves, andalign
themselves with the direction of the external field, showing up as a
hypo-exposed region on an MRI scan [11]. Iron-based magnetic
nanoparticles, such as Feridex, have mostly been used in vitro or in
vivo in experiments, for example in tracking themovement of stem
cells implanted into a wound site [12,13]. Nanoparticles are also
being put to use in the treatment of diseases. Gold nanoparticles are
being used as drug delivery systems [14,15], and somenanoparticles
have disease-countering intrinsic properties. Iron-based nanoparti-
cles have been targeted specifically to cancer cells viamesenchymal
stem cells able to home in on sites of tumorgenesis; when an
external magnetic field is applied the nanoparticles heat up, killing
the cancer cells via thermal damage [16]. Catalytic metallic nano-
particles have been developed for a wide array of reactions, from
palladium nanoparticles performing Suzuki reactions in the pro-
duction of styrenes [17] to oxygen reduction reactions in fuel cells
performed by platinum nanoparticles [18]. The current boom in
these nanoparticle catalysts is seeing extensive research carried out
in the design, production and optimisation of these catalysts [19].
Metalnanoparticles alsohave applications in electronics, photonics
and in environmental clean-up, amongst others. Clearly they are a
class of material with huge potential.
Metallic nanoparticles and synthetic biology
Synthetic biology involves the re-engineering of life to create
organisms capable of performing novel functions for industry,
medicine and scientific research. Synthetic biology could beenriched by exploring the possibilities metallic nanoparticles
provide, and the same is true vice versa; synthetic biology has
the potential to be a powerful tool in the production and functio-
nalisation of metal nanoparticles. The modular nature of synthetic
biology lends itself very well to metal nanoparticle production.
With the ability to swap modules in and out of a chassis it would
allow the production of nanoparticles based on many different
elements aswell as a largenumberof post-productionmodifications
to a core nanoparticle. By treating the nanoparticles as modular
many usefulmaterials can be produced. One area in which itmakes
sense to begin this joint effort is sensing, both in using nanopar-
ticles as sensors in synthetic biology applications and in using
synthetic biology to create methods of sensing the nanoparticles
themselves. Once reliable sensing methods have been developed
they can form the foundation for producing nanoparticles with
other properties, such as catalysts or conductive nanowires.
In creating metallic nanoparticle-based tools for synthetic biol-
ogy a good starting point would be quantum dots (QDs). QDs are a
class of nanocrystals that emit light of specific wavelengths with
the size of the nanoparticle determining thewavelength; the larger
the size, the higher the wavelength of the infra-red light emitted
[20]. A potential hazard in binding QDs to a protein of interest is
the fact that QDs can be multivalent. While it is relatively straight
forward to bind QDs to proteins, they are capable of additional
interactions with the protein andmay affect its function. To avoid
this complication a method has been developed using phosphor-
othioate DNA (ptDNA) to ‘wrap around’ commercially available
CdSe:ZnS QDs, blocking all other potential binding sites (Fig. 1).
The ptDNA can be further modified, such as by conjugation with
benzylguanine, a molecule which binds SNAP tags. This method
was successfully used to target ptDNA/QD particles to Notch
receptors carrying a SNAP tag; as CdSe:ZnS QDs emit light at
605 nm the location of these Notch receptors in the cells could
then be determined using an imaging microscope and a 488 nm
laser [21]. Such a sensing method could readily be applied to any
protein of interest. In synthetic biology it is often important to
determine the location of a protein of interest, such as ensuring a
protein of interest with a trans-membrane domain has been suc-
cessfully inserted into the membrane. The use of QDs in the
manner described would therefore be very useful.
Similarly it is possible to usemetal nanoparticles to detect single
proteins in situ inmammalian cells. 10 nmgold nanoparticles have
been producedwhich absorb a particular wavelength of lased light.
This absorption leads to a temperature change, changing the
refractive properties of the nanoparticle, which is detected using
a second laser. This method was successfully used to detect the
gold nanoparticle labelled-protein mGluR5 (a neurotransmitter-
receptor protein) within the cell membrane [22]. This method is a
less intrusive way of investigating the trafficking of individual
proteins compared to conjugating bulky fluorescence proteins to
the protein of interest.
There are also examples of synthetic biology projects with the
potential to act as sensors for metal nanoparticles. Synthetic
biology is already being used to create ways of sensing elemental
andmolecular forms ofmetals, and it is easy to see how these could
be modified and expanded upon to create ways of sensing metallic
nanoparticles. With the biological production of metal nanopar-
ticles becomingmore widespread such sensors would be useful in awww.elsevier.com/locate/nbt 573
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FIGURE 1
Linking materials to quantum dots. (a) Traditional method. Trithiolated DNA
(ttDNA) binding to quantum dots (gold spheres) yields multivalent and non-
conjugated products, as well as desired monovalent products. (b) Steric
exclusionmethod. Phosphorothioate DNA (ptDNA) is able to wrap around the
quantum dots, forming only monovalent products. (c) Subsequent 30
modification of the 30 end of the ptDNA allows the conjugation of the





erdetection system which gives a visual indication (e.g. by GFP)
when a certain concentration of nanoparticles has been pro-
duced, or as part of a feedback mechanism to turn off genes
involved in nanoparticle production. Additionally these sensors
could have a role to play in the traditional synthesis of metal
nanoparticles. It is possible to engineer high specificity in biolog-
ical detection systems, allowing the purity of the synthesised
nanoparticles to be assessed. One example of a metalloid-sensing
system that could be used as starting point in engineering nano-
particle-detecting systems uses Escherichia coli to sense the pres-
ence of arsenite [23]. The sensing is achieved by combining short-
range quorum sensing between cells within individual colonies
on the sub-mmscalewith an amplification systemwhich depends
on the longer range release and detection of gaseous metabolites
on the mm scale between different colonies. Individual cells
sensing arsenite communicate this to nearby cells in the colony.
This synchronised colony is then able to send out an alternative
and stronger signal to nearby colonies, bringing the reporter
mechanism above the detection threshold. The ‘nesting’ of com-
municationdescribedhere allows anybackground activity caused
by used fluctuations in the quorum signalling of a single colony to
be overcome, preventing false positives. The DNA constructs
encoding the sensing machinery include several different ele-
ments, including: an arsenite-responsive promoter, the luxR gene,574 www.elsevier.com/locate/nbtand a signal oscillation/reporter element (Fig. 2). This robust and
highly tuned sensing pathway with designed modularity could
easily be adapted to include any other substrate, such as ametallic
nanoparticle, and as such has wide applications.
Salmonella enterica is able to detect Fe(III) via the membrane
protein PmrB [24].When extracellular levels of iron are high, PmrB
auto-phosphorylates, and is then able to activate PmrA. This in
turn interacts with the promoters of genes involved in iron me-
tabolism and transport [24]. Work has been carried out to replace
the iron-sensing domain of PmrB with other metal-binding
domains; as there are no known wild type proteins capable of
binding to lanthanide group metals, artificial lanthanide-binding
peptides [25] have been used to replace the iron-binding domain
in PmrB in an E. coli chassis [26]. This strain also contains PmrA, as
well as a reporter gene such as GFP under the control of a PmrA-
controlled promoter. Thus when PmrB detects a lanthanide it is
specific to it activates PmrA, which in turn drives the production of
the reporter protein [26]. These are just two examples of how
synthetic biology has been put to use in the sensing of metal
substrates, and from being able to sense metal substrates it is
relatively easy to engineer systems to sense nanoparticles of those
metals. These systems would constitute a powerful tool in syn-
thetic biology, and produce a very customisable system for the
detection many substrates, including metal nanoparticles.
Bacterial/biological production of metal nanoparticles
As well as advances in sensing, synthetic biology offers new
approaches in the synthesis and modification of biological nano-
particles. While metallic nanoparticles are widely used in many
applications the current chemical and physical methods for their
synthesis can be problematic, often requiring high temperatures
and/or pressures, making them very energy intensive processes
and therefore expensive [27]. Additionally, the starting materials
for these methods can be expensive and often require very pure
grades of substrate. Biological synthesis, however, offers a number
of benefits over synthetic processes for nanoparticle production,
including: lower reaction temperatures, lower working pressures,
the use of a non-pure starting material and cheaper maintenance
of the ‘catalyst’ [27,28]. As such, there has been a lot of research
carried out using both prokaryotic and eukaryotic organisms to
produce metallic nanoparticles with some attributed applications.
Organisms generally make nanoparticles as part of their defence
against toxic metals. These organisms lower the toxicity of metal
ions by reducing them to elemental or less toxic/soluble forms as a
by-product of ATP synthesis, and often transport them outside of
the cell [29,30].
Both eukaryotes and prokaryotes are known to produce and
implement nanoparticles; a summary of the organisms covered in
this review and the types of nanoparticle they produce are given in
Table 1. One example of a eukaryotic nanoparticle producer is the
fungus Phoma, which produces silver nanoparticles as anti-bacte-
rial agents, and these have been found to have uses as catalysts in
the oil industry and for medical applications [27]. Fusarium oxy-
sporum produces nanoparticles of Pt, Zr, Ag, Au, Cd, Pb and Ti [31–
33], and themangrove plant Rhizophoramucronatahas been shown
to produce antimicrobial silver nanoparticles [34].
However, due to their faster growth rates and ease of manipula-
tion, nanoparticle-producing prokaryotes are the logical choice for
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FIGURE 2
Arsenic sensing system. (a) Schematic of the arsenite sensing construct. All of the genes are driven by a luxI promoter. The LuxI protein produces AHLwhich forms
a complex with LuxR; this drives expression from the luxI promoters in cells within the same colony, synchronising them. ndh encodes NDH-2, an enzyme that
generates H2O2 vapour; this diffuses to nearby colonies and activates the system there, synchronising them to the original colony. (b) Overview of colonies. AHL
diffuses intra-colonially, synchronising single colonies; H2O2 vapour diffuses inter-colonially, synchronising adjacent colonies. (c) Fluorescence produced by
synchronised colonies. Each square is one colony made up of approximately 500 cells [23].
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FIGURE 3
Bacteria containing magnetosomes (black circular structures) composed of
iron nanoparticles. Thin sections of sample were stained with 5% uranyl








erdeveloping nanoparticles in synthetic biology, especially since
many species of bacteria are able to produce nanoparticles natu-
rally. Sulphur reducing bacteria, such as Desulfovibrio, can reduce
certain metals such as Au, Pt and Pd to nanoparticle forms.
Palladium nanoparticles produced by Desulfovibrio have been
shown to be an effective catalyst in hydrogen fuel cells [35] while
palladisedDesulfovibrio cells have also been used in chromium (IV)
decontamination. These nanoparticles proved to be very stable,
lasting over eleven times longer than industrially produced palla-
dium nanoparticles [36].
A bacterium that utilises nanoparticles internally is Magnetos-
pirillum gryphiswaldense, which produces magnetic nanoparticles.
These aquatic magnetotactic bacteria produce magnetic nanocrys-
tals and encase them in membranes [37], forming structures
known as magnetosomes (Fig. 3) possibly for orientation and
chemotaxis purposes [38]. This offers the possibility of producing
‘pre-packaged’ nanoparticles.
As well as structures like the magnetosome, a form of nanopar-
ticle known as a nanowire is also produced naturally by some
organisms. In respiration under anaerobic conditions Shewanella
are able to transport electrons out of the cell along metal nano-
wires [39] (Fig. 4). The nanowires increase the surface area available
to the cell to ‘discharge’ electrons, increasing the rate of electron
transfer during respiration. As well as being investigated for their
potentially useful conductive properties the compounds produced
by the reduction carried out by the nanowires are also worthexploring. Of note is the fact that Shewanella produce nanowires
that are able to reduce silica ferrihydrite to magnetite (Fe3O4)
nanoparticles [39]; these have paramagnetic properties, and as
mentioned above are used as contrast agents in MRI [11].www.elsevier.com/locate/nbt 575
RESEARCH PAPER New Biotechnology Volume 31, Number 6 December 2014
[(Figure_4)TD$FIG]
FIGURE 4
Bacterial nanowires. (a) Scanning electron microscopy image of Shewanella
oneidensis producing nanowires. (b) Scanning tunnelling microscope image





erSome bacteria capable of reducing metals to nanoparticle forms
have been used in industrial applications. One such bacterium
highlighted in early work by Diels [40] is Cupriavidus metallidurans
(previouslyAlcaligenes eutrophus). It was shown that it could reduce
the metals Cd, Cu, Zn, Co, Ni, Pb, Pd, Y and Ge, when they were
present as soil contaminants at former industrial sites, precipitat-
ing them in carbonate forms that could be removed more easily.
This work points out how value can be added to the use of bacteria
as a remediation strategy; not only were the organisms used to
treat contaminated land but in future they might also be used to
retrieve metals for future use. It also showed that the use of non-
pure substrates, in this case soil, is also a possibility and puts to
work the bacteria’s highly selective ‘sieve-like’ nature to absorb
those useful metals and reduce them, often into pure elemental
forms of nanoparticle.
Another bacterium of potential industrial value is Pseudomonas,
which has recently been shown to produce a large array of nano-
particles; work by Srivastava [41] found that Pseudomonas pro-
duced nanoparticles of Ag, Pd, Fe, Rh, Ni, Ru, Pt and Co, and
surprisingly Li as well. All of the nanoparticles were produced at
room temperature (Fig. 5), highlighting how little energy is re-
quired for their synthesis compared to current methods [41].576 www.elsevier.com/locate/nbtCupriavidus and Pseudomonas together are able to produce a
large number of highly desirable metals in their wild-type forms;
it is easy to see how synthetic biology could be used to take such
diversity as a starting point and engineer bacteria for wider appli-
cations, such as contaminant identification/detoxification as well
as the specific production of a nanoparticle from a mixture of
substrates such as found in soil or water.
Possible limitations
As with most advancements in science and technology there are
potential drawbacks and controversial issues. Synthetic biology is
certainly no different; the end products are designed to be used in
real-life applications, often in areas where they have contact with
people outside of science, either in industry or medicine, and as
such is at the forefront of public debate. Additionally nanoparti-
cles are a relatively new class of material with characteristics quite
different to those of larger scale samples of the same material,
where even small differences in size lead to different catalytic
properties. Therefore, especially in medicine, the use of nanopar-
ticles is somewhat controversial. Quantum dots have uses in
medical research and diagnosis, but in other studies were found
to be toxic to cells in vivo, leading to an apparent discrepancy
between applications and implementations [42].
The problems with using nanoparticles are that for each
reported use they have different characteristics, different deriva-
tion or are being used in quite different systems, and very little is
yet known about their impact on the environment or in potential
patients [43]. The solution to this would be standardisation of the
nanoparticles used; this is something that is integral to synthetic
biology, as standardisation is fundamental to implementation and
ease of use. One illustrative example of how standardisation has
been implemented is in the form of Biobricks for bacterial genetic
manipulation [44,45]. The Biobrick project consists of a large
number of standard parts (such as genes and promoters) available
to anyone andwhich can be readily combined into new constructs
[46]. This engineering approach to synthetic biology offers a huge
number of possible biobrick functions.
As well as drawbacks found with metal nanoparticles them-
selves there are also potential pitfalls with their biological produc-
tion. Currentmethods will need to be optimised in order to ensure
that the metal nanoparticles are all of the desired size and compo-
sition. Itmay also be necessary to first engineer a chassis so that it is
able to survive in the presence of nanoparticles and their substrates
as these may prove toxic to the cells; as mentioned above many of
the natural pathways of nanoparticle synthesis in bacteria evolved
to deal with the toxicity of metal-containing compounds [29].
Additionally for schemes such as bioremediation there is the issue
of releasing engineered organisms into the environment. It would
therefore be necessary to use separate strains, using wild-type
organisms able to accumulate metals from contaminated land
and only using engineered nanoparticle-forming organisms in a
controlled environment.
It is the role of synthetic biology, as with all branches of science,
to innovate responsibly and to take great care with the synthesis of
new materials, and when synthetic biology-inspired standardisa-
tion methods and practices are implemented we can begin to
assess and control the impact nanoparticles and their production
have in applied systems and the environment.
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FIGURE 5









This review has explored many of the possibilities offered by
bringing together aspects of synthetic biology and metallic nano-
particles. Using metallic nanoparticle tools as part of synthetic
biology, and using synthetic biology to produce and modify
nanoparticles, both fields can achieve a great deal of synergy.
Synthetic biology is about adapting existing natural biological
capabilities to facilitate the solving of issues faced by science,
engineering and medicine. There is a large array of metallicnanoparticle-forming pathways that already exist in nature, ready
to be utilised by synthetic biology in producing ‘natural’ and
synthetic nanoparticles that are able to compete with industrial
products at commercial levels. Real-world applications, such as
using synthetic biology to create bacteria capable of cleaning up
former industrial sites and converting metal contaminants into
useful nanoparticles, are already being investigated. Further work
is needed, but unlocking the potential of combining metallic
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